Drugs / Holmium-166-DOTMP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00039754 | Mar 2002 → ? | plasma cell myeloma | Poniard Pharmaceuticals | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Holmium-166-DOTMP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00039754 ↗ |